Results 161 to 170 of about 43,575 (292)
Abstract INTRODUCTION Clinicopathological studies offer crucial interpretations of 18F‐flortaucipir (FTP) tau positron emission tomography (PET) signal but are limited by methods. We leveraged whole‐brain, quantitative immunohistochemical (IHC) Alzheimer's Disease (AD) tau density maps to comprehensively evaluate the FTP tracer.
Yishu Chao +9 more
wiley +1 more source
How does type 2 diabetes modify the risk of Alzheimer's disease?
Abstract Type 2 diabetes (T2D) and Alzheimer's disease (AD) are both increasing exponentially worldwide. T2D has also been identified as one of 14 modifiable risk factors for dementia, but the mechanism is unknown. T2D could promote dementia via vascular or AD neuropathological changes, and mechanistic hypotheses include central insulin resistance and ...
G. T. Sutherland +7 more
wiley +1 more source
The role of non-fungible tokens in education: A comprehensive review and future directions
Non-fungible tokens (NFTs) possess transformative potential in the educational sector, facilitating digital content creation, ownership, and exchange while fostering advancements in personalized learning, certification, and resource sharing.
Agariadne Dwinggo Samala +4 more
doaj +1 more source
Abstract— The rapid growth of blockchain technology has transformed the creation and exchange of digital assets through Non-Fungible Tokens (NFTs). Despite this progress, existing NFT marketplaces continue to face significant challenges, including high transaction costs, centralized metadata storage, lack of transparency in royalty distribution ...
SOUVIK DAS +4 more
openaire +1 more source
Abstract INTRODUCTION In Alzheimer's disease (AD), tau–neurodegeneration (T–N) mismatch has been proposed to reflect non‐AD processes such as transactive response DNA binding protein 43 kDa and vascular disease. We aimed to characterize the spatiotemporal trajectories of T–N mismatch that may reflect non‐AD progression.
Xueying Lyu +13 more
wiley +1 more source
PIB is a non-specific imaging marker of amyloid-beta (Aβ) peptide-related cerebral amyloidosis [PDF]
The in vivo imaging probe [11C]-PIB (Pittsburgh Compound B, N-methyl[11C]2-(4′-methylaminophenyl-6-hydroxybenzathiazole) is under evaluation as a key imaging tool in Alzheimer's disease (AD) and to date has been assumed to bind with high affinity and ...
Beach, T.G. +8 more
core
Abstract INTRODUCTION Down syndrome (DS) is the leading genetic cause of intellectual disability and Alzheimer's disease (AD), with over 90% of individuals developing AD‐related dementia (DSAD). The triplication of the APP gene on chromosome 21 drives early amyloid‐β (Aβ) accumulation, but other Hsa21 genes also contribute to pathology.
Monika Rataj Baniowska +18 more
wiley +1 more source
Advanced Non‐Enzymatic Electrochemical Sensor Materials for Alzheimer's Disease Biomarkers
This review summarizes advances in materials‐driven, non‐enzymatic electrochemical biosensors for early Alzheimer's diagnosis via biofluid analysis. Amyloid‐β and hyperphosphorylated Tau are highlighted alongside sensor performance metrics, including sensitivity and selectivity.
Wei‐Ting Ting +5 more
wiley +1 more source
ABSTRACT Purpose Alzheimer's disease (AD) is a progressive neurodegenerative disorder involving amyloid‐β deposition, tau hyperphosphorylation, oxidative stress, and neuroinflammation. This review systematically evaluates the neuroprotective effects of Litchi chinensis and its phytochemicals against AD, focusing on modulation of Aβ accumulation, tau ...
Emon Mia +11 more
wiley +1 more source
ABSTRACT The apparel industry is one of the world's most profitable sectors but also among the most environmentally damaging. Growing sustainability pressures have led companies to adopt diverse strategies to reduce their impact, yet no single study has systematically analysed these approaches or their consumer implications.
Maria Leonor Ferreira +1 more
wiley +1 more source

